Quantinuum Inc. (NASDAQ:QNT – Get Free Report) has been given a consensus rating of “Moderate Buy” by the fourteen analysts that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $98.75.
QNT has been the topic of a number of research reports. UBS Group initiated coverage on shares of Quantinuum in a research report on Monday, June 29th. They issued a “buy” rating and a $93.00 price objective on the stock. Cantor Fitzgerald began coverage on shares of Quantinuum in a research report on Monday, June 29th. They issued an “overweight” rating and a $90.00 target price for the company. Evercore initiated coverage on shares of Quantinuum in a research note on Monday, June 29th. They issued an “outperform” rating and a $98.00 price target on the stock. Sanford C. Bernstein assumed coverage on shares of Quantinuum in a research note on Monday, June 29th. They set an “outperform” rating and a $94.00 price objective for the company. Finally, Zacks Research upgraded Quantinuum to a “hold” rating in a report on Tuesday, June 30th.
Read Our Latest Research Report on QNT
Quantinuum Price Performance
Insider Activity
In related news, Director Hal Barron acquired 250,000 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $60.00 per share, with a total value of $15,000,000.00. Following the acquisition, the director owned 255,833 shares in the company, valued at $15,349,980. This represents a 4,285.96% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Manish H. Bhatia bought 20,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was purchased at an average cost of $60.00 per share, with a total value of $1,200,000.00. Following the completion of the purchase, the director directly owned 25,833 shares of the company’s stock, valued at $1,549,980. This represents a 342.88% increase in their position. The SEC filing for this purchase provides additional information. In the last ninety days, insiders acquired 411,032 shares of company stock valued at $24,661,920.
Quantinuum Company Profile
Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.
The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.
See Also
- Five stocks we like better than Quantinuum
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
